CLINICAL_TRIALS
trial_result
· 2024-04-30
Clinical Trial Update: Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 trial comparing oral vinorelbine plus capecitabine against taxane-gemcitabine combinations as first-line therapy in metastatic breast cancer, with resul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pierre Fabre Medicament | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-04-30